RecallDepth
Class II Terminated

Helix CBD Therapy Cream (Menthol 7.4%), packaged in a) 3 g pouch (NDC 30775-053-01), b) 2 fl. oz. tubes (NDC 30775-053-02), c) 4 fl. oz. tubes (NDC 30775-053-04), Parker Laboratories Inc., Fairfield, NJ, 07004

This recall has been terminated (originally issued August 30, 2023).

Company
Parker Laboratories, Inc.
Recall Initiated
August 2, 2023
Posted
August 30, 2023
Recall Number
D-1092-2023
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
40
Firm Location
Fairfield, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations

Distribution

Nationwide within the United States, Singapore, Korea and Hong Kong

Lot / Code Info

Lot #: a) J1121010, Exp. Date 12/16/2023, b) A0921006, Exp. Date 8/16/2023, c) A0921007, Exp. Date 8/16/2023

More recalls by Parker Laboratories, Inc.

View all recalls by this company →

Other recent Class II Drug recalls